BUPROPION\NALTREXONE: 7,763 Adverse Event Reports & Safety Profile
Lose Weight Fast — The 21-Day Smoothie Diet
36 fat-burning recipes + shopping lists. Results in the first week.
7,763
Total FAERS Reports
30 (0.4%)
Deaths Reported
628
Hospitalizations
7,763
As Primary/Secondary Suspect
76
Life-Threatening
102
Disabilities
Active Ingredient: BUPROPION HYDROCHLORIDE\NALTREXONE HYDROCHLORIDE ·
First Report: 19230410 · Latest Report: 20250908
What Are the Most Common BUPROPION\NALTREXONE Side Effects?
#1 Most Reported
Nausea
1,857 reports (23.9%)
#2 Most Reported
Headache
1,054 reports (13.6%)
#3 Most Reported
Dizziness
986 reports (12.7%)
All BUPROPION\NALTREXONE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Nausea | 1,857 | 23.9% | 0 | 113 |
| Headache | 1,054 | 13.6% | 0 | 69 |
| Dizziness | 986 | 12.7% | 0 | 61 |
| Vomiting | 646 | 8.3% | 0 | 64 |
| Constipation | 602 | 7.8% | 0 | 30 |
| Feeling abnormal | 550 | 7.1% | 0 | 35 |
| Fatigue | 474 | 6.1% | 1 | 30 |
| Anxiety | 378 | 4.9% | 0 | 28 |
| Insomnia | 367 | 4.7% | 0 | 34 |
| Diarrhoea | 350 | 4.5% | 0 | 28 |
| Patient dissatisfaction with treatment | 340 | 4.4% | 0 | 9 |
| Drug titration error | 338 | 4.4% | 0 | 44 |
| Blood pressure increased | 322 | 4.2% | 0 | 36 |
| Drug ineffective | 313 | 4.0% | 0 | 6 |
| Tremor | 306 | 3.9% | 0 | 21 |
| Illness | 290 | 3.7% | 0 | 13 |
| Dry mouth | 279 | 3.6% | 0 | 22 |
| Malaise | 268 | 3.5% | 0 | 18 |
| Weight increased | 255 | 3.3% | 0 | 21 |
| Abdominal pain upper | 252 | 3.3% | 0 | 30 |
Who Reports BUPROPION\NALTREXONE Side Effects? Age & Gender Data
Gender: 87.6% female, 12.4% male. Average age: 50.0 years. Most reports from: US. View detailed demographics →
Is BUPROPION\NALTREXONE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2001 | 1 | 0 | 0 |
| 2002 | 1 | 0 | 0 |
| 2003 | 1 | 0 | 0 |
| 2011 | 1 | 0 | 0 |
| 2012 | 1 | 0 | 1 |
| 2013 | 5 | 1 | 2 |
| 2014 | 58 | 1 | 7 |
| 2015 | 755 | 2 | 44 |
| 2016 | 356 | 3 | 32 |
| 2017 | 169 | 0 | 40 |
| 2018 | 165 | 2 | 31 |
| 2019 | 264 | 1 | 24 |
| 2020 | 328 | 1 | 29 |
| 2021 | 356 | 3 | 34 |
| 2022 | 560 | 0 | 59 |
| 2023 | 894 | 0 | 52 |
| 2024 | 432 | 1 | 44 |
| 2025 | 64 | 0 | 16 |
What Is BUPROPION\NALTREXONE Used For?
| Indication | Reports |
|---|---|
| Weight control | 2,842 |
| Product used for unknown indication | 2,801 |
| Overweight | 803 |
| Obesity | 726 |
| Weight decreased | 426 |
| Decreased appetite | 35 |
| Depression | 24 |
| Weight increased | 17 |
| Food craving | 13 |
| Anxiety | 9 |
BUPROPION\NALTREXONE vs Alternatives: Which Is Safer?
BUPROPION\NALTREXONE vs BUROSUMAB
BUPROPION\NALTREXONE vs BUROSUMAB-TWZA
BUPROPION\NALTREXONE vs BUSPIRONE
BUPROPION\NALTREXONE vs BUSULFAN
BUPROPION\NALTREXONE vs BUSULFEX
BUPROPION\NALTREXONE vs BUTALBITAL
BUPROPION\NALTREXONE vs BUTENAFINE
BUPROPION\NALTREXONE vs BUTORPHANOL
BUPROPION\NALTREXONE vs BUTRANS
BUPROPION\NALTREXONE vs BUTYLSCOPOLAMINE
Official FDA Label for BUPROPION\NALTREXONE
Official prescribing information from the FDA-approved drug label.